FDA allows new tools for testing of Zika virus - UPI.com
UPI reports: "The U.S. Food and Drug Administration has made available a panel of
human plasma samples to aid in the regulatory evaluation of serological
tests for Zika.
In 2017, there were 203 cases of symptomatic Zika virus reported in the
United States, according to the Centers for Disease Control and
Prevention..
The FDA's sample panel is comprised of plasma samples from anonymous
patients infected with the Zika virus, West Nile virus, or dengue virus. [...] The use of the same serological panel can help public health professionals compare the effectiveness of different Zika virus tests."
No comments:
Post a Comment